[New approaches to the treatment of Felty's syndrome].
Nasonova
V A
VA
Balabanova
R M
RM
Alekberova
Z S
ZS
Solov'ev
S K
SK
Chiklikchi
A S
AS
D000328:Adult; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004112:Dimercaprol / Q000008:administration & dosage / Q000031:analogs & derivatives; D004359:Drug Therapy, Combination; D005258:Felty Syndrome / Q000628:therapy*; D005260:Female; D006464:Hemoperfusion; D006801:Humans; D008297:Male; D008667:Metalloproteins / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D050607:Organogold Compounds; D009942:Organometallic Compounds; D010956:Plasmapheresis; D011239:Prednisolone / Q000008:administration & dosage; D020005:Propanols; D013438:Sulfhydryl Compounds
D008667:Metalloproteins; D050607:Organogold Compounds; D009942:Organometallic Compounds; D020005:Propanols; D013438:Sulfhydryl Compounds; D004112:Dimercaprol; D003520:Cyclophosphamide; D011239:Prednisolone; C013394:aurotioprol; D008727:Methotrexate
Novye podkhody k lecheniiu sindroma Felti.